US Stock MarketDetailed Quotes

TNDM Tandem Diabetes Care

Watchlist
  • 33.470
  • +0.860+2.64%
Close Feb 14 16:00 ET
  • 33.470
  • 0.0000.00%
Post 20:01 ET
2.20BMarket Cap-17.25P/E (TTM)

Tandem Diabetes Care Key Stats

Tandem Diabetes Care Q4 2024 Estimates Date

Currency:USDFeb 26, 2025

Estimate YoY
Revenue
251.39M
+27.74%
EPS
-0.18
+61.62%
Strong Buy

Feb 8, 2025

Tandem Diabetes Care Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 220.698M--
Feb 26, 20252024/Q4-- / 251.390M--
Nov 6, 20242024/Q3243.971M / 224.123M--
Aug 1, 20242024/Q2221.910M / 205.871M--
May 2, 20242024/Q1191.674M / 173.537M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 220.698M--
Feb 26, 20252024/Q4-- / 251.390M--
Nov 6, 20242024/Q3243.971M / 224.123M--
Aug 1, 20242024/Q2221.910M / 205.871M--
May 2, 20242024/Q1191.674M / 173.537M--

Unlock Free Earnings Estimates

Tandem Diabetes Care Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 8, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data